Navigating Grey Areas in HIV and Mental Health Implementation Science

Overview

Journal J Int AIDS Soc

Specialty Infectious Diseases

Date 2024 Jun 26

PMID 38923301

Authors

Audrey Harkness

Ali Giusto

Alison B Hamilton

Raul U Hernandez-Ramirez

Donna Spiegelman

Bryan J Weiner

Rinad S Beidas

Michaela E Larson

Sheri A Lippman

Milton L Wainberg

Justin D Smith

Affiliations

Soon will be listed here.

Abstract

Introduction: Implementation science (IS) offers methods to systematically achieve the Ending the HIV Epidemic goals in the United States, as well as the global UNAIDS targets. Federal funders such as the National Institutes of Mental Health (NIMH) have invested in implementation research to achieve these goals, including supporting the AIDS Research Centres (ARCs), which focus on high-impact science in HIV and mental health (MH). To facilitate capacity building for the HIV/MH research workforce in IS, "grey areas," or areas of IS that are confusing, particularly for new investigators, should be addressed in the context of HIV/MH research.

Discussion: A group of IS experts affiliated with NIMH-funded ARCs convened to identify common and challenging grey areas. The group generated a preliminary list of 19 grey areas in HIV/MH-related IS. From the list, the authors developed a survey which was distributed to all ARCs to prioritize grey areas to address in this paper. ARC members across the United States (N = 60) identified priority grey areas requiring clarification. This commentary discusses topics with 40% or more endorsement. The top grey areas that ARC members identified were: (1) Differentiating implementation strategies from interventions; (2) Determining when an intervention has sufficient evidence for adaptation; (3) Integrating recipient perspectives into HIV/MH implementation research; (4) Evaluating whether an implementation strategy is evidence-based; (5) Identifying rigorous approaches for evaluating the impact of implementation strategies in the absence of a control group or randomization; and (6) Addressing innovation in HIV/MH IS grants. The commentary addresses each grey area by drawing from the existing literature (when available), providing expert guidance on addressing each in the context of HIV/MH research, and providing domestic and global HIV and HIV/MH case examples that address these grey areas.

Conclusions: HIV/MH IS is key to achieving domestic and international goals for ending HIV transmission and mitigating its impact. Guidance offered in this paper can help to overcome challenges to rigorous and high-impact HIV/MH implementation research.

References

Proctor E, Powell B, Baumann A, Hamilton A, Santens R . Writing implementation research grant proposals: ten key ingredients. Implement Sci. 2012; 7:96. PMC: 3541090. DOI: 10.1186/1748-5908-7-96. View

Craig P, Katikireddi S, Leyland A, Popham F . Natural Experiments: An Overview of Methods, Approaches, and Contributions to Public Health Intervention Research. Annu Rev Public Health. 2017; 38:39-56. PMC: 6485604. DOI: 10.1146/annurev-publhealth-031816-044327. View

Mthembu J, Hamilton A, Milburn N, Sinclair D, Mkabile S, Mashego M . "It Had a Lot of Cultural Stuff in It": HIV-Serodiscordant African American Couples' Experiences of a Culturally Congruent Sexual Health Intervention. Ethn Dis. 2020; 30(2):269-276. PMC: 7186048. DOI: 10.18865/ed.30.2.269. View

Smith J, Li D, Rafferty M . The Implementation Research Logic Model: a method for planning, executing, reporting, and synthesizing implementation projects. Implement Sci. 2020; 15(1):84. PMC: 7523057. DOI: 10.1186/s13012-020-01041-8. View

Zombre D, De Allegri M, Ridde V . Immediate and sustained effects of user fee exemption on healthcare utilization among children under five in Burkina Faso: A controlled interrupted time-series analysis. Soc Sci Med. 2017; 179:27-35. DOI: 10.1016/j.socscimed.2017.02.027. View

Pyra M, Motley D, Bouris A . Moving toward equity: fostering transdisciplinary research between the social and behavioral sciences and implementation science to end the HIV epidemic. Curr Opin HIV AIDS. 2022; 17(2):89-99. DOI: 10.1097/COH.0000000000000726. View

Smith J, Li D, Merle J, Keiser B, Mustanski B, Benbow N . Adjunctive interventions: change methods directed at recipients that support uptake and use of health innovations. Implement Sci. 2024; 19(1):10. PMC: 10854146. DOI: 10.1186/s13012-024-01345-z. View

Lyon A, Bruns E . User-Centered Redesign of Evidence-Based Psychosocial Interventions to Enhance Implementation-Hospitable Soil or Better Seeds?. JAMA Psychiatry. 2018; 76(1):3-4. DOI: 10.1001/jamapsychiatry.2018.3060. View

Queiroz A, Mongrella M, Keiser B, Li D, Benbow N, Mustanski B . Profile of the Portfolio of NIH-Funded HIV Implementation Research Projects to Inform Ending the HIV Epidemic Strategies. J Acquir Immune Defic Syndr. 2022; 90(S1):S23-S31. PMC: 10204808. DOI: 10.1097/QAI.0000000000002962. View

10.

Gustafson P, Abdul Aziz Y, Lambert M, Bartholomew K, Rankin N, Fusheini A . A scoping review of equity-focused implementation theories, models and frameworks in healthcare and their application in addressing ethnicity-related health inequities. Implement Sci. 2023; 18(1):51. PMC: 10578009. DOI: 10.1186/s13012-023-01304-0. View

11.

Schwartz S, Smith J, Hoffmann C, Hansoti B, Mishra S, Means A . Implementing Implementation Research: Teaching Implementation Research to HIV Researchers. Curr HIV/AIDS Rep. 2021; 18(3):186-197. DOI: 10.1007/s11904-021-00551-4. View

12.

Hamilton A, Brown A, Loeb T, Chin D, Grills C, Cooley-Strickland M . Enhancing patient and organizational readiness for cardiovascular risk reduction among Black and Latinx patients living with HIV: Study protocol. Prog Cardiovasc Dis. 2020; 63(2):101-108. PMC: 7266485. DOI: 10.1016/j.pcad.2020.02.014. View

13.

Beidas R, Saldana L, Shelton R . Testing psychosocial interventions in the contexts they are meant to be delivered. J Consult Clin Psychol. 2023; 91(4):189-191. PMC: 10175148. DOI: 10.1037/ccp0000797. View

14.

Esposti M, Spreckelsen T, Gasparrini A, Wiebe D, Bonander C, Yakubovich A . Can synthetic controls improve causal inference in interrupted time series evaluations of public health interventions?. Int J Epidemiol. 2020; 49(6):2010-2020. DOI: 10.1093/ije/dyaa152. View

15.

Aarons G, Sklar M, Mustanski B, Benbow N, Brown C . "Scaling-out" evidence-based interventions to new populations or new health care delivery systems. Implement Sci. 2017; 12(1):111. PMC: 5588712. DOI: 10.1186/s13012-017-0640-6. View

16.

Bernal J, Cummins S, Gasparrini A . Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2016; 46(1):348-355. PMC: 5407170. DOI: 10.1093/ije/dyw098. View

17.

Smith J, Carroll A, Sanuade O, Johnson R, Abramsohn E, Abbas H . Process of Engaging Community and Scientific Partners in the Development of the CIRCL-Chicago Study Protocol. Ethn Dis. 2024; DECIPHeR(Spec Issue):18-26. PMC: 11895547. DOI: 10.18865/ed.DECIPHeR.18. View

18.

Kratochwill T, Levin J, Morin K, Lindstrom E . Examining and Enhancing the Methodological Quality of Nonconcurrent Multiple-Baseline Designs. Perspect Behav Sci. 2022; 45(3):651-660. PMC: 9458816. DOI: 10.1007/s40614-022-00341-2. View

19.

Gibbons R, Brown C, Hur K, Marcus S, Bhaumik D, Erkens J . Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry. 2007; 164(9):1356-63. DOI: 10.1176/appi.ajp.2007.07030454. View

20.

Wertz D, Hou L, DeVries A, Dupclay Jr L, McGowan F, Malinowski B . Clinical and economic outcomes of the Cincinnati Pharmacy Coaching Program for diabetes and hypertension. Manag Care. 2012; 21(3):44-54. View